Lim JJ, Nilsson AC, Silverman M, Assy N, et al. A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a
monoclonal antibody, plus oseltamivir in patients hospitalized with severe
influenza A infection. Antimicrob Agents Chemother 2020 May 11. pii: AAC.00352.
PMID: 32393496